FDA — authorised 26 February 2010
- Marketing authorisation holder: SHIRE HUMAN GENETIC
- Status: approved
🇺🇸 Vpriv in United States
FDA authorised Vpriv on 26 February 2010
Marketing authorisations
FDA — authorised 26 February 2010
- Application: BLA022575
- Marketing authorisation holder: SHIRE HUMAN GENETIC
- Local brand name: VPRIV
- Indication: POWDER — INTRAVENOUS
- Status: approved
Vpriv in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Vpriv approved in United States?
Yes. FDA authorised it on 26 February 2010; FDA authorised it on 26 February 2010.
Who is the marketing authorisation holder for Vpriv in United States?
SHIRE HUMAN GENETIC holds the US marketing authorisation.